Valuation: Hypera S.A.

Market Cap 14.85B 2.91B 2.54B 2.35B 2.17B 4.11B 277B 4.18B 28.02B 11B 137B 10.91B 10.68B 469B P/E 2026 *
7.77x
P/E 2027 * 6.58x
Enterprise Value 20.92B 4.1B 3.58B 3.3B 3.05B 5.79B 391B 5.89B 39.48B 15.5B 192B 15.38B 15.04B 661B EV / Sales 2026 *
2.26x
EV / Sales 2027 * 2.02x
Free-Float
38.88%
Yield 2026 *
5.37%
Yield 2027 * 5.75%
1 day+3.28%
1 week-1.92%
Current month-0.55%
1 month+1.24%
3 months-12.97%
6 months-11.09%
Current year-1.15%
1 week 3.96
Extreme 3.96
4.11
1 month 3.8
Extreme 3.8
4.29
Current year 3.8
Extreme 3.8
5.5
1 year 3.71
Extreme 3.71
5.5
3 years 2.64
Extreme 2.64
9.43
5 years 2.64
Extreme 2.64
10.08
10 years 2.64
Extreme 2.64
11.98
Manager TitleAgeSince
Chief Executive Officer 50 23/04/2019
Director of Finance/CFO 38 23/02/2022
Chief Operating Officer 40 31/12/2019
Director TitleAgeSince
Director/Board Member 77 31/05/2007
Director/Board Member 60 31/05/2007
Director/Board Member 52 25/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
+3.28%-1.92% - - 2.91B
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -0.73%-3.25%+26.72%+56.70% 397.1B
Weighted average by Cap. -1.31%-2.96%+36.75%+83.91%

Financials

2026 *2027 *
Net sales 9.24B 1.81B 1.58B 1.46B 1.35B 2.56B 173B 2.6B 17.44B 6.85B 84.98B 6.79B 6.64B 292B 10.01B 1.96B 1.71B 1.58B 1.46B 2.77B 187B 2.82B 18.89B 7.42B 92.07B 7.36B 7.2B 317B
Net income 1.9B 372M 325M 300M 277M 526M 35.49B 535M 3.59B 1.41B 17.48B 1.4B 1.37B 60.1B 2.26B 442M 386M 356M 329M 624M 42.11B 635M 4.26B 1.67B 20.75B 1.66B 1.62B 71.32B
Net Debt 6.07B 1.19B 1.04B 959M 886M 1.68B 113B 1.71B 11.46B 4.5B 55.84B 4.46B 4.37B 192B 5.41B 1.06B 926M 854M 789M 1.5B 101B 1.52B 10.21B 4.01B 49.76B 3.98B 3.89B 171B
Logo Hypera S.A.
Hypera (formerly Hypermarcas) is the Brazilian leader in the manufacture and marketing of pharmaceutical products. The products are sold primarily under the Addera D3, Adocyl, AdultMax, Alivium, Apracur, Atroveran, Benegrip, Bigfral, Biotonico Fontoura, Coristina, Cremer, Doril, Engov, Epocler, Lisador and Neo Quimica. The activity is organized around 3 families of products : - OTC medicines; - prescription medicines; - branded generic medicines.
Employees
10,564
Date Price Change Volume
10/07/26 US$4.090 +3.28% 2,969
09/07/26 US$3.960 0.00% 10,408
08/07/26 US$3.960 -1.99% 6,981
07/07/26 US$4.040 -0.43% 102,160
06/07/26 US$4.058 -2.69% 2,240
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
21.11BRL
Average target price
29.57BRL
Spread / Average Target
+40.08%

Quarterly revenue - Rate of surprise